Tag - RMED

Developments

Ra Medical begins patient enrollment in pivotal atherectomy study

Ra Medical Systems (NASDAQ:RMED) enrolled the first patient in its pivotal study of the DABRA excimer laser system for the treatment of peripheral vascular stenoses. DABRA is an atherectomy device that uses...

February 27, 2020

Markets

Piper cuts Ra Medical to neutral; PT to $1.50 from $9

Piper Jaffray downgraded Ra Medical Systems (NASDAQ:RMED) to “neutral” from “overweight” and slashed its price target to $1.50 from $9 after the company disclosed several operating issues in its preliminary second...

August 13, 2019

Tag - RMED

Ra Medical begins patient enrollment in pivotal atherectomy study

Piper cuts Ra Medical to neutral; PT to $1.50 from $9

General

More